Table 2 Functional activity of Dezocine at human κ-, rat μ, or rat δ-opioid receptors.
Compounds | Agonist activity | Antagonist activity | |||||||
|---|---|---|---|---|---|---|---|---|---|
MOR | KOR | DOR | MOR | KOR | DOR | ||||
EC50 (nM) | Emax (%) | EC50 (nM) | Emax (%) | EC50 (nM) | Emax (%) | Ke (nM) | Ke (nM) | Ke (nM) | |
DAMGO | 16.1 ± 0.3 | 240.7 ± 33.8 | c | c | c | c | c | c | c |
U50,488 H | c | c | 5.6 ± 1.2 | 198.9 ± 7.5 | c | c | c | c | c |
DPDPE | c | c | c | c | 1.4 ± 0.2 | 231.3 ± 7.1 | c | c | c |
Dezocine | b | 45.8 ± 1.1d | b | 33.6 ± 2.4d | b | 26.1 ± 1.0d | 10.4 ± 4.9 | 324.1 ± 23.6 | a |